Prentiss Christopher B

Chief Financial Officer at Adamas Pharmaceuticals Inc

Sold, on record
$96k
Dollars the filings state
Form 4 sales
9
Latest Mar 22, 2021
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale Adamas Pharmaceuticals IncPlan not stated
    Dec 20, 2018 2018

    Sold 228 shares at $7.51 ($2k)

    Prentiss Christopher B, Chief Accounting Officer

    Sold 1.2% of holdings ($139k position)18,226 shares leftFiling

  2. 2 Form 4 sale Adamas Pharmaceuticals IncPlan not stated
    Mar 20, 2019 +90 days

    Sold 1,185 shares at $8.00 ($9k)

    Prentiss Christopher B, Chief Accounting Officer

    Sold 3.9% of holdings ($246k position)29,541 shares leftFiling

  3. 3 Form 4 sale Adamas Pharmaceuticals IncPlan not stated
    Jul 22, 2019 +124 days

    Sold 1,082 shares at $6.00 ($6k)

    Prentiss Christopher B, Chief Accounting Officer

    Sold 2.2% of holdings ($290k position)47,209 shares left1.9x usual sizeFiling

  4. 4 Form 4 sale Adamas Pharmaceuticals IncPlan not stated
    Jan 21, 2020 +183 days

    Sold 1,269 shares at $5.92 ($8k)

    Prentiss Christopher B, Chief Financial Officer

    Sold 1.8% of holdings ($427k position)70,940 shares left1.5x usual sizeFiling

  5. 5 Form 4 sale Adamas Pharmaceuticals IncPlan not stated
    Nov 2, 2020 +286 days

    Sold 2,050 shares at $3.21 ($7k)

    Prentiss Christopher B, Chief Financial Officer

    Sold 2.5% of holdings ($260k position)78,890 shares left1.8x usual sizeFiling

  6. 6 Form 4 sale Adamas Pharmaceuticals IncPlan not stated
    Jan 20, 2021 +79 days

    Sold 2,630 shares at $4.41 ($12k)

    Prentiss Christopher B, Chief Financial Officer

    Sold 3.3% of holdings ($348k position)76,260 shares left2.1x usual sizeFiling

  7. 7 Form 4 sale Adamas Pharmaceuticals IncUnusual
    Feb 1, 2021 +12 days

    Sold 3,821 shares at $6.36 ($24k)

    Prentiss Christopher B, Chief Financial Officer

    Sold 5% of holdings ($485k position)72,439 shares left3x usual sizeFiling

  8. 8 Form 4 sale Adamas Pharmaceuticals IncPlan not stated
    Mar 22, 2021 +49 days

    Sold 2,422 shares at $5.48 ($13k)

    Prentiss Christopher B, Chief Financial Officer

    Sold 1.6% of holdings ($808k position)145,017 shares left1.2x usual sizeFiling

Every transaction

Loading transactions…

Sales and notices (9)

Form 144 notices and Form 4 sales by Prentiss Christopher B
Source
Mar 22, 2021Mar 23, 2021Adamas Pharmaceuticals IncChief Financial OfficerForm 4 sale2,422$13k1.6%Plan not statedSEC
Feb 1, 2021Feb 1, 2021Adamas Pharmaceuticals IncChief Financial OfficerForm 4 sale3,821$24k5.0%UnusualSEC
Jan 20, 2021Jan 22, 2021Adamas Pharmaceuticals IncChief Financial OfficerForm 4 sale2,630$12k3.3%Plan not statedSEC
Nov 2, 2020Nov 2, 2020Adamas Pharmaceuticals IncChief Financial OfficerForm 4 sale2,050$7k2.5%Plan not statedSEC
Jan 21, 2020Jan 23, 2020Adamas Pharmaceuticals IncChief Financial OfficerForm 4 sale1,269$8k1.8%Plan not statedSEC
Jul 22, 2019Jul 23, 2019Adamas Pharmaceuticals IncChief Accounting OfficerForm 4 sale1,082$6k2.2%Plan not statedSEC
Mar 20, 2019Mar 21, 2019Adamas Pharmaceuticals IncChief Accounting OfficerForm 4 sale1,185$9k3.9%Plan not statedSEC
Dec 20, 2018Dec 26, 2018Adamas Pharmaceuticals IncChief Accounting OfficerForm 4 sale228$2k1.2%Plan not statedSEC
Mar 21, 2018Mar 22, 2018Adamas Pharmaceuticals IncChief Accounting OfficerForm 4 sale567$15k3.1%Plan not statedSEC